drugset / Trial / NCT02957448

A Study to Evaluate the Effect of Rifampin on the Single-dose Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects

NCT02957448

Phase 1 Completed 16 enrolled Bristol-Myers Squibb
NaSingle-groupOpen-labelBasic science

Summary

This study is to evaluate the effect of multiple doses of rifampin on the single-dose PK of BMS 986141 with parameters like Cmax, AUC(INF), AUC(0-T), AUC(0-144h)

Timeline

Start
2016-11
Primary completion
2017-01
Completion
2017-01

Drugs

EvaluationDrugModalityDoseRoute
Subject BMS-986141 Small molecule
Subject Rifampin Small molecule